120 related articles for article (PubMed ID: 38604406)
21. Characteristics and causes of pre-donation deferrals at a Chinese blood center.
Yang Y
Transfus Apher Sci; 2021 Aug; 60(4):103153. PubMed ID: 34016553
[TBL] [Abstract][Full Text] [Related]
22. Analysis of reasons of blood donor deferral at a tertiary care institute in India and its reflections on community health status.
Malhotra S; Negi G
Asian J Transfus Sci; 2023; 17(1):48-52. PubMed ID: 37188024
[TBL] [Abstract][Full Text] [Related]
23. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy.
Spekman MLC; Ramondt S; Sweegers MG
Transfusion; 2021 Apr; 61(4):1112-1121. PubMed ID: 33368385
[TBL] [Abstract][Full Text] [Related]
24. Assessment of motivations for return donation among deferred blood donors. American Red Cross ARCNET Study Group.
Munsterman KA; Grindon AJ; Sullivan MT; Trouern-Trend J; Blackmon MJ; Watkins J; Williams AE
Transfusion; 1998 Jan; 38(1):45-50. PubMed ID: 9482393
[TBL] [Abstract][Full Text] [Related]
25. Stigmatizing deferrals disproportionally reduce donor return rates: Evidence from Brazil.
Vieites Y; Ferreira CM; Goldszmidt R; Andrade EB
Vox Sang; 2024 Jun; 119(6):606-611. PubMed ID: 38425028
[TBL] [Abstract][Full Text] [Related]
26. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
[TBL] [Abstract][Full Text] [Related]
27. Notifying donors when their deferral is ending: An effective donor retention strategy.
Gemelli CN; Thijsen A; Van Dyke N; Kruse SP; Davison TE
Transfusion; 2021 Oct; 61(10):2930-2940. PubMed ID: 34352927
[TBL] [Abstract][Full Text] [Related]
28. Whole blood donor deferral rate and characteristics of the Turkish population.
Arslan O
Transfus Med; 2007 Oct; 17(5):379-83. PubMed ID: 17725552
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of iron education through a mobile application on donor return after deferral for low hemoglobin.
Hasan MI; Noordin SS; Hami R; Ishak N; Achuthan A
Blood Transfus; 2022 Nov; 20(6):446-453. PubMed ID: 35848625
[TBL] [Abstract][Full Text] [Related]
30. The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China.
Xiao G; Dong D; Wang Y; Li C; Huang GT; Yang H; Huang J; Chen F
PeerJ; 2023; 11():e14999. PubMed ID: 36935911
[TBL] [Abstract][Full Text] [Related]
31. Changes in the Whole Blood Donor Population in South-West Germany: 2010 versus 2016.
Müller-Steinhardt M; Weidmann C; Klüter H
Transfus Med Hemother; 2017 Aug; 44(4):217-223. PubMed ID: 28924426
[TBL] [Abstract][Full Text] [Related]
32. The impact of donor selection on blood safety in Iran.
Razjou F; Maghsudlu M; Nasizadeh S; Zadsar M
Transfus Apher Sci; 2012 Aug; 47(1):13-6. PubMed ID: 22521567
[TBL] [Abstract][Full Text] [Related]
33. Educating donors about deferrals through the provision of tailored materials: Findings from a survey of deferred donors.
Gemelli CN; Kruse SP; Thijsen A; Van Dyke N; Davison TE
Transfusion; 2021 Mar; 61(3):822-829. PubMed ID: 33615506
[TBL] [Abstract][Full Text] [Related]
34. Blood donor selection and deferral pattern as an important tool for blood safety in a tertiary care hospital.
Shrivastava M; Shah N; Navaid S; Agarwal K; Sharma G
Asian J Transfus Sci; 2016; 10(2):122-6. PubMed ID: 27605848
[TBL] [Abstract][Full Text] [Related]
35. Temporary deferral and donor return.
Piliavin JA
Transfusion; 1987; 27(2):199-200. PubMed ID: 3824481
[TBL] [Abstract][Full Text] [Related]
36. Rates and reasons for blood donor deferral, Shiraz, Iran. A retrospective study.
Kasraian L; Negarestani N
Sao Paulo Med J; 2015 Feb; 133(1):36-42. PubMed ID: 25166463
[TBL] [Abstract][Full Text] [Related]
37. Review of blood donor deferral with emphasis on donor and patient safety.
Lamba DS; Sachdev S; Hans R; Krishan Dhawan H; Sharma RR; Marwaha N
Transfus Clin Biol; 2023 Feb; 30(1):56-62. PubMed ID: 35835317
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
[TBL] [Abstract][Full Text] [Related]
39. New tatt? We're ok with that! Relaxing the tattoo deferral for plasmapheresis donors maintains safety and increases donations.
Styles CE; Hoad VC; Harley R; Kaldor J; Gosbell IB
Vox Sang; 2024 Jun; ():. PubMed ID: 38925639
[TBL] [Abstract][Full Text] [Related]
40. Blood donation behaviour and attitudes towards the 12-month deferral policy among gay and bisexual men in New Zealand.
Sriamporn KT; Saxton P; Consedine N; Hammoud M; Prestage G
Vox Sang; 2022 Oct; 117(10):1145-1152. PubMed ID: 35919939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]